Krishnaswamy Yeleswaram sold $2.5M of Rapport Therapeutics (RAPP)

Executed Aug 24, disclosed Aug 26, 2 days later.

Value, as filed

$2.5M

50,160 sh across 3 lots

Executed

Aug 24

the trade date, as filed

Disclosed

Aug 26

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Krishnaswamy Yeleswaram Chief Development Officer profile →

Krishnaswamy Yeleswaram (Chief Development Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $2.5M of RAPP (50,160 sh across 3 lots, as filed), executed Aug 24.

The name

RAPP

Rapport Therapeutics, Inc. RAPP · Healthcare · 32 filings in 24 months ticker →

Healthcare · Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transfo…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Krishnaswamy Yeleswaram in RAPP

RAPPSALE Rapport Therapeutics, Inc. $809K
20,225 sh × $39.99
Exec Apr 17
Filed Apr 21 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. $678K
19,365 sh across 2 lots
Exec Apr 13
Filed Apr 14 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. $303K
10,115 sh × $29.99
Exec Mar 25
Filed Mar 26 · 5:30 PM ET